Recent studies introduce hepatocellular carcinoma photosensitizers that utilize intramolecular π-π stacking to significantly amplify reactive oxygen species (ROS) production. Furthermore, this breakthrough modular geminal-tetraphenylethylene (gem-TPE) platform offers a highly targeted approach for treating liver cancer. Specifically, the platform integrates asialoglycoprotein receptor (ASGPR)-targeting GalNAc units with aryl-rich organelle-directing motifs. Consequently, these structural features regulate intramolecular packing and photophysical behavior to enhance therapeutic precision.

Advancing Hepatocellular Carcinoma Photosensitizers via Molecular Stacking

The research team systematically investigated a series of derivatives, including gem-TPEVP-TsG and gem-TPEVP-FBG. Moreover, ROS probe assays and EPR spectroscopy confirmed that these organelle-modified derivatives exhibit dual Type I and Type II photoreactivity. Notably, the gem-TPEVP-TsG derivative produced approximately 3.6-fold higher Type I ROS compared to non-stacking controls. In addition, theoretical calculations revealed that aryl-rich substituents promote intramolecular π-π stacking at a distance of approximately 3.4 Å. Therefore, this interaction induces conformational rigidity and enhances intersystem crossing in the non-aggregated state.

Consequently, confocal microscopy confirmed efficient ASGPR-mediated uptake and a predominant lysosomal distribution within cancer cells. This specific localization likely arises from π-π-driven molecular folding. Furthermore, all tested derivatives displayed light-dependent cytotoxic responses that tracked with ROS generation trends. In contrast, they maintained negligible dark effects, suggesting high safety for clinical applications. Moreover, this design strategy provides a general framework to enhance ROS generation while preserving essential aqueous solubility for systemic delivery.

Frequently Asked Questions

How do these photosensitizers target liver cancer cells?

The photosensitizers use GalNAc functional units to target the asialoglycoprotein receptor (ASGPR), which is highly expressed on the surface of hepatocellular carcinoma cells. This ensures selective uptake and reduces damage to healthy tissues.

What is the role of intramolecular π-π stacking in this therapy?

Intramolecular π-π stacking induces conformational rigidity within the molecule. This structural stability promotes intersystem crossing, which significantly boosts the production of reactive oxygen species (ROS) needed to destroy tumor cells.

Is this treatment safe for non-cancerous cells?

Yes, the study indicated that these derivatives maintain negligible dark toxicity. The cytotoxic effects are light-dependent, meaning they only become active when triggered by specific light wavelengths during treatment.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.

References

Li YJ et al. Intramolecular π-π stacking-regulated ROS amplification in water-soluble GalNAc-functionalized tetraphenylethylene photosensitizers for hepatocellular carcinoma. J Mater Chem B. 2026 Mar 10. doi: 10.1039/d5tb02740c. PMID: 41804767.

Grolez GP et al. Photodynamic Therapy Using a Rose-Bengal Photosensitizer for Hepatocellular Carcinoma Treatment: Proposition for a Novel Green LED-Based Device for In Vitro Investigation. Biomedicines. 2024 Sep 18;12(9):2120. doi: 10.3390/biomedicines12092120. PMID: 39335633.